Pancreatic Adenocarcinoma Resectable clinical trials

Explore recruiting pancreatic adenocarcinoma resectable clinical trials.

Recruiting pancreatic adenocarcinoma resectable studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatic Adenocarcinoma Resectable trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase I/randomized Phase II, open-label multicenter trial to evaluate the safety, tolerability, and efficacy of mFOLFIRINOX with or without BNT321 as adjuvant therapy following curative resection in patients with pancreatic adenocarcinoma

Denmark, Spain, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

KISIMA-02 vaccine-based immunotherapy for patients with mutated pancreatic cancer

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

KISIMA-02 vaccine-based immunotherapy for patients with pancreatic cancer

France, Spain, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Pancreatic Adenocarcinoma Resectable trials by city

Pancreatic Adenocarcinoma Resectable in Toronto Pancreatic Adenocarcinoma Resectable in Vancouver Pancreatic Adenocarcinoma Resectable in Montreal Pancreatic Adenocarcinoma Resectable in Calgary Pancreatic Adenocarcinoma Resectable in Edmonton Pancreatic Adenocarcinoma Resectable in Ottawa Pancreatic Adenocarcinoma Resectable in Winnipeg Pancreatic Adenocarcinoma Resectable in Quebec City Pancreatic Adenocarcinoma Resectable in Hamilton Pancreatic Adenocarcinoma Resectable in Kitchener Pancreatic Adenocarcinoma Resectable in London Pancreatic Adenocarcinoma Resectable in Halifax Pancreatic Adenocarcinoma Resectable in New York Pancreatic Adenocarcinoma Resectable in Los Angeles Pancreatic Adenocarcinoma Resectable in Chicago Pancreatic Adenocarcinoma Resectable in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease